Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

MASCT-I Combined With Apatinib and/or Camrelizumab in the Treatment of Bone and Soft Tissue Sarcoma

HRYZ Biotech Co. · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
sarcoma, masct-i, cell-based immunotherapy, camrelizumab, apatinib, tumor associated antigen, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 862410
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.